|
ARHGAP32 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.198200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58658999999117E-05 |
| Normal-vs-Stage2 |
7.668300E-02 |
| Normal-vs-Stage3 |
6.403600E-01 |
| Normal-vs-Stage4 |
2.555000E-01 |
| Stage1-vs-Stage2 |
4.535600E-01 |
| Stage1-vs-Stage3 |
2.540200E-03 |
| Stage1-vs-Stage4 |
3.86320000000939E-06 |
| Stage2-vs-Stage3 |
1.700430E-01 |
| Stage2-vs-Stage4 |
1.946040E-02 |
| Stage3-vs-Stage4 |
1.875820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.795400E-03 |
| Normal-vs-AfricanAmerican |
8.798000E-01 |
| Normal-vs-Asian |
5.206800E-01 |
| Caucasian-vs-AfricanAmerican |
1.409430E-01 |
| Caucasian-vs-Asian |
9.262800E-01 |
| AfricanAmerican-vs-Asian |
5.765000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.732780E-01 |
| Normal-vs-Female |
4.387699999997E-05 |
| Male-vs-Female |
1.478690E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.576400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.353500E-04 |
| Normal-vs-Age(61-80Yrs) |
6.886100E-02 |
| Normal-vs-Age(81-100Yrs) |
3.173200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.162200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.708190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.225400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.002810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.876000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.848400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.316500E-03 |
| Normal-vs-Grade 2 |
1.12210000002833E-06 |
| Normal-vs-Grade 3 |
8.366400E-02 |
| Normal-vs-Grade 4 |
5.557500E-04 |
| Grade 1-vs-Grade 2 |
8.213800E-02 |
| Grade 1-vs-Grade 3 |
3.180700E-03 |
| Grade 1-vs-Grade 4 |
1.14819999952331E-07 |
| Grade 2-vs-Grade 3 |
3.017300E-03 |
| Grade 2-vs-Grade 4 |
3.13515879923898E-12 |
| Grade 3-vs-Grade 4 |
1.46400000000657E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62614366416847E-12 |
| Normal-vs-ccB subtype |
1.037940E-02 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.601500E-03 |
| Normal-vs-N1 |
6.414500E-04 |
| N0-vs-N1 |
1.219710E-04 |
|
|
